ARCHIVES

Three Institutes To Test BioMicro’s Microarray Product. GlycoDesign Allowed Patent For Cancer Drug GD0039.

This article is from The Cancer Letter archive.

Vol. 28 No. 09 | March 1, 2002

Download PDF Visit The Full Archive

Related Articles

In Brief: Senate approves $13.69 Billion for NIH, House To Act This Week; Amounts Are Close

September 19, 1997

Ethics Commission Acknowledges Weak Case For Mandatory Patient Compensation

April 23, 1982

FDA Urges Lower Target for ESA Use; Market Could Drop By More Than Half.

March 16, 2007

Weinstein Applauds Investigation Report

September 26, 1997

Decade-Long Cover-up?

January 6, 1995

New Treatment Approaches for Leukemias Emerging From Early Clinical Trials

December 31, 2004